Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
05/26SIGNIFICANT RISE FOR BIOLOGICAL SENS : The report offers a comprehensive evaluat..
AQ
05/25STUDY RESULTS FROM JOHNSON & JOHNSON : Pathways and Mechanisms)
AQ
05/25JOHNSON & JOHNSON : Janssen Pharmaceutical - New Real-World Study Finds Long-Ter..
AQ
05/25JOHNSON & JOHNSON : EU nod for Sandoz Remicade biosimilar Zessly
AQ
05/25JOHNSON & JOHNSON : Jury delivers $25M verdict in Johnson & Johnson asbestos cas..
AQ
05/25JOHNSON & JOHNSON : Absorbs Another Loss in Baby Powder-Mesothelioma Case
AQ
05/25JOHNSON & JOHNSON : Ex-dividend day for
FA
05/24JOHNSON & JOHNSON : Jury awards $25M in Johnson & Johnson baby powder lawsuit
AQ
05/24JOHNSON & JOHNSON : Jury recommends $25M in Johnson & Johnson lawsuit
AQ
05/24JOHNSON & JOHNSON : to Participate in the Jefferies 2018 Global Healthcare Confe..
PU
More news
News from SeekingAlpha
03:20aDIVIDEND SENSEI'S PORTFOLIO UPDATE 3 : To Get Rich First, You Need To Do One Ver.. 
05/27Bristol-Myers Squibb Is One Stock That You Should Not Ignore 
05/263 THINGS IN BIOTECH, MAY 25 : A CLL Game Changer 
05/26Know When To Hold 'Em 
05/25Kezar Life Sciences on deck for IPO 
Financials ($)
Sales 2018 81 536 M
EBIT 2018 24 881 M
Net income 2018 16 279 M
Debt 2018 9 501 M
Yield 2018 2,97%
P/E ratio 2018 17,99
P/E ratio 2019 16,69
EV / Sales 2018 4,11x
EV / Sales 2019 3,77x
Capitalization 326 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 145 $
Spread / Average Target 19%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-11.45%325 801
PFIZER-0.91%208 713
NOVARTIS-8.30%194 397
ROCHE HOLDING LTD.-9.17%189 708
MERCK AND COMPANY5.01%158 970
AMGEN2.33%117 942